Thomas Tang

2.4k total citations · 1 hit paper
19 papers, 1.6k citations indexed

About

Thomas Tang is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Obstetrics and Gynecology. According to data from OpenAlex, Thomas Tang has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 12 papers in Public Health, Environmental and Occupational Health and 4 papers in Obstetrics and Gynecology. Recurrent topics in Thomas Tang's work include Ovarian function and disorders (13 papers), Reproductive Biology and Fertility (10 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Thomas Tang is often cited by papers focused on Ovarian function and disorders (13 papers), Reproductive Biology and Fertility (10 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Thomas Tang collaborates with scholars based in United Kingdom, Australia and United States. Thomas Tang's co-authors include Adam Balen, Robert J. Norman, Jonathan Lord, Ephia Yasmin, Julian H. Barth, Lara Morley, Davinia White, Julie Glanville, Catherine Hayden and Nicolas M. Orsi and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Human Reproduction and Human Reproduction Update.

In The Last Decade

Thomas Tang

19 papers receiving 1.5k citations

Hit Papers

Insulin-sensitising drugs (metformin, rosiglitazone, piog... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Tang United Kingdom 12 1.3k 960 292 220 176 19 1.6k
Maurizio Guido Italy 23 1.3k 1.1× 845 0.9× 369 1.3× 166 0.8× 189 1.1× 94 1.7k
Paulina A. Essah United States 18 1.5k 1.2× 997 1.0× 519 1.8× 142 0.6× 113 0.6× 23 2.1k
Maria J. Iuorno United States 17 1.9k 1.5× 1.3k 1.3× 576 2.0× 248 1.1× 174 1.0× 20 2.4k
Angeliki T Bergiele Greece 8 1.4k 1.1× 913 1.0× 372 1.3× 98 0.4× 149 0.8× 8 1.6k
Miryam Asunción Spain 7 1.1k 0.9× 714 0.7× 280 1.0× 97 0.4× 212 1.2× 11 1.4k
Saad Amer United Kingdom 24 1.6k 1.2× 954 1.0× 100 0.3× 186 0.8× 101 0.6× 63 1.8k
Chryssa Kouli Greece 6 1.4k 1.1× 919 1.0× 413 1.4× 77 0.3× 134 0.8× 6 1.6k
Soulmaz Shorakae Australia 15 587 0.5× 380 0.4× 165 0.6× 81 0.4× 72 0.4× 27 892
Eleni Κousta United Kingdom 19 494 0.4× 378 0.4× 301 1.0× 194 0.9× 138 0.8× 40 1.2k
Rosa Alba Longo Italy 13 1.1k 0.9× 670 0.7× 310 1.1× 43 0.2× 137 0.8× 13 1.3k

Countries citing papers authored by Thomas Tang

Since Specialization
Citations

This map shows the geographic impact of Thomas Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Tang more than expected).

Fields of papers citing papers by Thomas Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Tang. The network helps show where Thomas Tang may publish in the future.

Co-authorship network of co-authors of Thomas Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Tang. A scholar is included among the top collaborators of Thomas Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Tang. Thomas Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tang, Thomas. (2023). Comparison of machine learning methods for estimating customer churn in the telecommunication industry. Applied and Computational Engineering. 17(1). 157–162. 1 indexed citations
2.
Tang, Thomas, et al.. (2022). Spotlight on… clinical governance and patient safety. The Obstetrician & Gynaecologist. 24(4). 224–226. 1 indexed citations
3.
Sharpe, Abigail, Lara Morley, Thomas Tang, Robert J. Norman, & Adam Balen. (2019). Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews. 2019(12). CD013505–CD013505. 79 indexed citations
4.
Morley, Lara, Thomas Tang, Ephia Yasmin, Robert J. Norman, & Adam Balen. (2017). Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews. 2018(2). 192 indexed citations
5.
Talaulikar, Vikram, Thomas Tang, & Ephia Yasmin. (2016). Role of Metformin in Women’s Health. Obstetrical & Gynecological Survey. 71(5). 307–317. 13 indexed citations
6.
Rodger, Matthew, et al.. (2016). Current understanding of learning psychomotor skills and the impact on teaching laparoscopic surgical skills. The Obstetrician & Gynaecologist. 18(1). 53–63. 16 indexed citations
7.
Browne, Hannah, Gerald Mason, & Thomas Tang. (2014). Retinoids and pregnancy: an update. The Obstetrician & Gynaecologist. 16(1). 7–11. 23 indexed citations
8.
Morley, Lara, et al.. (2013). Preventing recurrent miscarriage of unknown aetiology. The Obstetrician & Gynaecologist. 15(2). 99–105. 7 indexed citations
9.
Morley, Lara, Nigel Simpson, & Thomas Tang. (2013). Human chorionic gonadotrophin (hCG) for preventing miscarriage. Cochrane Database of Systematic Reviews. 2013(1). CD008611–CD008611. 31 indexed citations
10.
Tang, Thomas & Adam Balen. (2012). Use of metformin for women with polycystic ovary syndrome†. Human Reproduction Update. 19(1). 1–1. 15 indexed citations
11.
Balen, Adam, et al.. (2012). Current issues in ovulation induction. The Obstetrician & Gynaecologist. 14(3). 188–196. 3 indexed citations
12.
Tang, Thomas, Jonathan Lord, Robert J. Norman, Ephia Yasmin, & Adam Balen. (2012). Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews. 11(5). CD003053–CD003053. 468 indexed citations breakdown →
14.
Tang, Thomas, Jonathan Lord, Robert J. Norman, Ephia Yasmin, & Adam Balen. (2009). Insulin-sensitising drugs for polycystic ovary syndrome. Cochrane Database of Systematic Reviews. CD003053–CD003053. 3 indexed citations
15.
Tang, Thomas & Adam Balen. (2009). A woman with polycystic ovary syndrome treated for infertility by in vitro fertilization. Nature Reviews Endocrinology. 5(8). 462–465. 1 indexed citations
16.
Tang, Thomas, Julie Glanville, Catherine Hayden, et al.. (2006). Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study. Obstetrical & Gynecological Survey. 61(2). 108–109. 59 indexed citations
17.
Tang, Thomas, Julie Glanville, Nicolas M. Orsi, Julian H. Barth, & Adam Balen. (2006). The use of metformin for women with PCOS undergoing IVF treatment. Human Reproduction. 21(6). 1416–1425. 143 indexed citations
18.
Tang, Thomas, Julie Glanville, Catherine Hayden, et al.. (2005). Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Human Reproduction. 21(1). 80–89. 236 indexed citations
19.
Tang, Thomas, et al.. (2003). Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database of Systematic Reviews. CD003053–CD003053. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026